Rickettsia are obligate intracellular bacteria that evade antimicrobial autophagy in the host cell cytosol by unknown mechanisms. Other cytosolic pathogens block different steps of autophagy targeting, including the initial step of polyubiquitin-coat formation. One mechanism of evasion is to mobilize actin to the bacterial surface. Here, we show that actin mobilization is insufficient to block autophagy recognition of the pathogen Rickettsia parkeri. Instead, R. parkeri employs outer membrane protein B (OmpB) to block ubiquitylation of the bacterial surface proteins, including OmpA, and subsequent recognition by autophagy receptors. OmpB is also required for the formation of a capsule-like layer. Although OmpB is dispensable for bacterial growth in endothelial cells, it is essential for R. parkeri to block autophagy in macrophages and to colonize mice because of its ability to promote autophagy evasion in immune cells. Our results indicate that OmpB acts as a protective shield to obstruct autophagy recognition, thereby revealing a distinctive bacterial mechanism to evade antimicrobial autophagy.
M embers of the diverse and clinically important Rickettsiae genus of Gram-negative obligate intracellular bacteria primarily reside in arthropod vectors such as ticks. During their life cycle, Rickettsia are often transmitted from arthropods to mammals, which can function as amplifying hosts that transfer bacteria to naive arthropods [1] [2] [3] . Some Rickettsia species can be transmitted to humans and cause diseases, including spotted fever and typhus 4, 5 . In mammalian infections, Rickettsia species primarily target vascular endothelial cells, although they can reside in a wide variety of cell types, including dendritic cells 6 and macrophages 7, 8 .
The intracellular life cycle of Rickettsia begins when bacteria adhere to and invade host cells. They subsequently escape the primary vacuole into the cytosol, where they replicate and must evade antimicrobial autophagy, a process that removes intracellular pathogens similarly to damaged organelles such as mitochondria 9, 10 . Antimicrobial autophagy often involves the recognition of bacteria by the host ubiquitin machinery, which covalently attaches ubiquitin to proteins, ultimately forming a polyubiquitin coat on cytosolic bacteria [11] [12] [13] . This promotes binding to autophagy receptors, such as p62 (ref. 14, 15 ) and NDP52 (ref. 15, 16 ). To initiate antimicrobial autophagy, double-membrane structures are nucleated by proteins including Beclin 1 17, 18 and then expanded through the activity of LC3. Lipidation and recruitment of LC3 to double-membrane structures by the ATG5-ATG12-ATG16L1 complex 19, 20 enables the capture of bacteria labelled with autophagy receptors, thereby leading to autophagosome maturation and bacterial degradation after fusion with lysosomes 21 .
Several facultative intracellular bacterial pathogens that grow in the host cell cytosol have evolved mechanisms to evade autophagic recognition 9, [21] [22] [23] [24] . For example, Listeria monocytogenes uses its surface protein ActA to avoid the formation of a polyubiquitin coat by masking the bacterial surface with components of the host actin machinery 22 as well as inducing actin polymerization and intracellular motility 11, 25 . It remains unclear whether or how other pathogens avoid polyubiquitin-coat formation and what microbial proteins are ubiquitylated by the host.
Rickettsia are highly adapted to the intracellular environment and thus have probably also evolved mechanisms to evade autophagic recognition 26 (although it was recently demonstrated that Rickettsia conorii benefits from autophagy in mouse macrophages 27 ). However, the bacterial factors that protect Rickettsia from the formation of a polyubiquitin coat are unknown.
To better understand the role of bacterial proteins in shielding against autophagic recognition, we investigated the function of the Rickettsia parkeri surface proteins outer membrane protein A (OmpA) 28, 29 , outer membrane protein B (OmpB) 28, 30 , the actin polymerizing protein Sca2 (ref. [31] [32] [33] ) and the 17-kDa antigen 34 . We found that Sca2-mediated actin polymerization is not protective. Instead, R. parkeri uses an unanticipated strategy, which is dependent on OmpB, an abundant and conserved rickettsial protein 28, 30, [35] [36] [37] . The importance of OmpB is cell-type-specific, as it is essential for growth and avoidance of autophagy in macrophages but not in endothelial cells. Strikingly, OmpB is also crucial for the colonization of mice by R. parkeri by allowing bacteria to evade autophagy. Our results suggest that cytosolic pathogens have evolved distinctive mechanisms to shield themselves from the formation of a polyubiquitin coat to avoid destruction via autophagy.
Results
OmpB is required for the avoidance of polyubiquitylation. To identify the surface proteins that may protect Rickettsia from autophagic recognition, we assessed whether R. parkeri transposon mutants lacking known surface proteins were polyubiquitylated. In particular, we assessed strains with transposon (tn) mutations in ompA, ompB, sca2 and hrtA (encoding the 17-kDa antigen) 33, 38 . The ompB mutant (ompB STOP ::tn), obtained by serial-passaging the parental ompB::tn strain, contains a suppressor mutation in the form of a stop codon upstream of the transposon that prevents expression of a truncated OmpB product, which seems to be toxic Articles NAturE MIcrOBIOlOgy ( Fig. 1b and Extended Data Fig. 1a-d) . The mutants were analysed for co-localization with polyubiquitin at 72 h post infection (h.p.i.) in human dermal microvascular endothelial cells (HMECs; Fig. 1a ,c and Extended Data Fig. 1e ). Wild-type (WT), ompA::tn and hrtA::tn bacteria were polyubiquitin negative. Notably, the sca2::tn mutant, which is defective in actin polymerization at this time point 33 , was also polyubiquitin negative. However, more than 75% of the ompB STOP ::tn (and ompB PROM ::tn, an independent mutant; Extended Data Fig. 1a-e ) bacteria co-localized with polyubiquitin. We tested R. parkeri mutants with insertions in the genes directly upstream or downstream of ompB to confirm whether the polyubiquitylation of ompB STOP ::tn bacteria was due to mutations in ompB and not polar effects on the surrounding genes ( Fig. 1b) . We also tested a mutant with an insertion in the gene rickCE encoding a rickettsial deubiquitylase 39 . Mutants with insertions in the genes directly flanking ompB, or in rickCE, were all polyubiquitin negative (Fig. 1a,c) . Thus, the polyubiquitylation of ompB STOP ::tn bacteria is caused by mutations in ompB. Furthermore, purified ompB STOP ::tn bacteria were heavily polyubiquitylated, whereas WT bacteria showed little polyubiquitylation (Fig. 1d ), suggesting that bacterial proteins or tightly associated host components are ubiquitylated. These data demonstrate that R. parkeri showing the cellular and bacterial genomic DNA (blue; Hoechst), polyubiquitin (red; FK1 antibody) and a merged image at 72 h.p.i. Note that the ompA::tn bacteria were not detected with the anti-Rickettsia antibody but could be visualized with the Hoechst stain. Scale bars, 5 μm. b, Diagram of ompB and the surrounding genes in the indicated mutants, showing the location of the transposon insertions in: ompB (at base pair (bp) position 1045462 in the R. parkeri genome; NCBI accession no. NC_017044.1); MC1_RS05535, hypothetical protein (at bp position 1040923) and MC1_RS05545, pseudogene (at bp position 1047186). The premature stop codon (STOP) suppressor mutation in ompB STOP ::tn (a 23-bp deletion at position 1045835-1045857) is also indicated. Note that the genome of the ompB STOP ::tn mutant was sequenced and the only mutations were in ompB (see extended Data Fig. 1 and the Data availability section). c, Percentage of bacteria that showed rim-like surface localization of polyubiquitin at 72 h.p.i. Data are the mean ± s.e.m.; n = 4 (WT and ompB STOP ::tn), 3 (MC1_RS05535::tn, MC1_RS05545::tn, ompA::tn and sca2::tn) and 2 (hrtA::tn and rickCE::tn); ≥110 bacteria were counted in each infection. Statistical comparisons between ompB STOP ::tn and WT, MC1_ RS05535::tn, MC1_RS05545::tn, ompA::tn and sca2::tn bacteria were performed using an unpaired Student's t-test (two-sided); ***P < 0.001. d, Western blot of gradient-purified WT and ompB STOP ::tn bacteria probed for host polyubiquitin and the R. parkeri rickA protein as a loading control (n = 2).
In macrophages, OmpB blocks polyubiquitylation and is essential for bacterial growth. Because spotted-fever-group Rickettsia also grow in macrophages in vitro 8 and in vivo 7 , we next assessed the internalization and polyubiquitylation kinetics of the ompB STOP ::tn mutant in mouse bone-marrow-derived macrophages (BMDMs). In contrast with their slower internalization into HMECs, ompB STOP ::tn bacteria reached internalization max into BMDMs at rates similar to WT bacteria (Extended Data Fig. 4a ), which suggests that OmpB does not impact the internalization of Rickettsia into macrophages. The ompB STOP ::tn mutant also showed an increase in co-localization with polyubiquitin with time, corresponding with internalization, and polyubiquitylated bacteria were primarily intracellular at 60 m.p.i. (Extended Data Fig. 4b-d ). These data demonstrate that the host ubiquitin machinery targets ompB STOP ::tn bacteria after their phagocytosis by BMDMs. We also measured bacterial growth over 96 h. In contrast with their robust growth in HMECs, ompB STOP ::tn were unable to grow in BMDMs, whereas WT bacteria increased approximately 50-fold in number ( Fig. 2g ). Failure to grow was also observed using immunofluorescence microscopy, which revealed that ompB STOP ::tn bacteria were rare, whereas WT bacteria were abundant in infected cells (Extended Data Fig. 5a-d ). In addition, failure of the ompB STOP ::tn bacteria to grow in BMDMs was not due to host cell death (Extended Data Fig. 5c-f ). Thus, OmpB is critical for the growth of R. parkeri in macrophages.
OmpB is required for the formation of an electron-lucent halo around cytosolic Rickettsia. We next assessed the role of OmpB in intracellular trafficking and morphology of R. parkeri using transmission electron microscopy (TEM). At 1 h.p.i., the majority of WT and ompB STOP ::tn bacteria had escaped from the phagosome and were in the host cytosol of HMECs and BMDMs ( Fig. 3a-d ). However, in comparison with WT bacteria, there was a reduction in the percentage of ompB STOP ::tn bacteria in the cytosol of HMECs and a corresponding increase in bacteria associated with single-membrane vacuoles ( Fig. 3a,b) , which was probably a consequence of a delayed invasion ( Fig. 2a ). No differences were observed between the percentage of ompB STOP ::tn and WT bacteria located in the cytosol of BMDMs (Fig. 3c,d ). Collectively, these data further suggest that the restriction of growth of the ompB STOP ::tn bacteria in BMDMs occurs following escape into the cytosol.
Once in the cytosol, ompB STOP ::tn bacteria exhibited increased association with membranes resembling phagophores, which localized near one bacterial pole or partly surrounding bacteria ( Fig. 3a-d ). However, ompB STOP ::tn and WT bacteria were comparable in their relatively rare localization within double-membrane vacuoles or electron-dense lysosomal compartments at 1 h.p.i. At 72 h.p.i., the majority of both ompB STOP ::tn and WT bacteria in HMECs were free of associated membranes (Fig. 3e ). These observations suggest that OmpB inhibits the association of cytosolic R. parkeri with host membranes shortly after infection.
The size of ompB STOP ::tn and WT bacteria was indistinguishable in HMECs, whereas the ompB STOP ::tn mutant was slightly smaller than the WT in BMDMs at 1 h.p.i. (Fig. 3g ). However, a striking difference was that ompB STOP ::tn bacteria lacked the electron-lucent capsule-like halo that surrounded the WT ( Fig. 3a-d ), ompA::tn, and MC1_RS05535::tn R. parkeri (Extended Data Fig. 6a,b ), as well as R. rickettsii 41, 42 . The size of the electron-lucent halo of WT bacteria was 100 ± 40 nm (mean ± s.d.) in BMDMs and 84 ± 60 nm in HMECs at 1 h.p.i. (Fig. 3f ). In HMECs, the mean thickness decreased to 22 ± 21 nm at 72 h.p.i. and many WT bacteria lacked a visible halo ( Fig. 3e,f ). These data demonstrate that R. parkeri is surrounded by an electron-lucent halo, which decreases in thickness during the time course of an infection, and that OmpB is required for the formation of this halo but not for other basic structural properties of the bacteria.
OmpB shields rickettsial surface proteins from ubiquitylation.
We next sought to identify proteins that are substrates of ubiquitylation on ompB STOP ::tn bacteria. We developed an approach that combined polyubiquitin enrichment from the surface fraction of bacteria with mass spectrometry to detect Lys-diGly (diGly) remnants, a signature for ubiquitin ( Fig. 4a ). We did not identify 
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any candidate host protein that was reproducibly enriched over fivefold in fractions from ompB STOP ::tn in comparison to WT bacteria ( Supplementary Table 1 ). However, we identified a bacterial peptide of OmpA with diGly remnants that was consistently enriched in fractions from ompB STOP ::tn bacteria (Fig. 4b ). The ubiquitylated lysine identified on OmpA is predicted to be exposed to the host cytosol ( Fig. 4c ), and OmpA was shifted towards a higher molecular mass in the ompB STOP ::tn compared with WT bacteria after ubiquitin enrichment ( Fig. 4d ).
To validate whether OmpA is ubiquitylated, we overexpressed 6×His-tagged ubiquitin in Vero, HMEC and A549 cells, and then assessed the association of His-tagged ubiquitin with bacteria by immunofluorescence microscopy or affinity purification of Hisubiquitin followed by western blotting. His-ubiquitin co-localized with ompB STOP ::tn but not WT bacteria during infection ( Fig. 4e ; data from Vero cells). Furthermore, OmpA was detected in Hisubiquitin-enriched fractions from ompB STOP ::tn but not WT bacteria, with a size shift that reflects ubiquitin chains of different lengths for the enrichment of polyubiquitylated proteins from the bacterial surface fraction prior to analysis using liquid chromatography-mass spectrometry (LC-MS). Note that TUBe-1 is pan-specific and binds most ubiquitin linkages. b, Heat map representation of bacterial proteins for which there is enrichment of Lys-diGly peptides (blue boxes) in ompB STOP ::tn compared with WT bacteria or equal abundance (white boxes) between ompB STOP ::tn and WT bacteria following analysis as per a. Data were from n = 2 (exp 1 and exp 2) independent experiments performed as technical triplicates. c, Predicted structure of the candidate substrate OmpA with the identified diGly site shown as a yellow circle. d, Western blot of polyubiquitin-enriched samples from gradient-purified bacteria (prepared as in a), probed for OmpA (residual detection of OmpA from WT bacteria is likely to be due to non-specific binding to the TUBe-1 beads) and rickA (as a bacterial loading control). The asterisk shows the size shift of OmpA, indicating that it is ubiquitylated (n = 2). e, Immunofluorescence micrographs of Vero cells expressing 6×His-ubiquitin and infected with WT or ompB STOP ::tn bacteria for 24 h, showing bacterial genomic DNA (blue, Hoechst) and 6×His-ubiquitin (red, anti-His antibody; n = 3). Scale bars, 5 μm. f, Western blot of Ni-NTA affinity-purified samples from control cells and cells expressing 6×His-ubiquitin, infected with WT or ompB STOP ::tn bacteria for 26 h and probed for OmpA or polyubiquitin (FK1). The asterisks indicate that OmpA from 6×His-ubiquitin-expressing cells infected with ompB STOP ::tn exhibits higher molecular weights than endogenous OmpA, which is consistent with ubiquitylation (Vero, n = 4; HMeC and A549, n = 2).
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OmpB is required for the avoidance of autophagic recognition in diverse host cells. Based on the ubiquitylation of ompB STOP ::tn bacteria, we hypothesized that OmpB is important for the avoidance of autophagic recognition. To test this, we first infected both HMECs and BMDMs, and then stained for the autophagic receptors p62 and NDP52 ( Fig. 5a-d ). More than 30% of ompB STOP ::tn bacteria colocalized with p62 and NDP52 at 1 h.p.i. in both cell types and in HMECs at 72 h.p.i., whereas fewer than 5% of the WT bacteria were associated with these proteins (Fig. 5g,h) . OmpB is thus crucial for avoiding association with p62 and NDP52.
We also assessed the recruitment of LC3, a common marker for autophagic membranes. A subpopulation of ompB STOP ::tn bacteria was associated with LC3 in both BMDMs and HMECs, with a peak in LC3 association at 2 h.p.i. and diminishing association thereafter, whereas WT bacteria showed little LC3 association ( Fig. 5e ,f,i,j; no difference in the numbers of cellular LC3 puncta was observed in cells infected with WT versus ompB STOP ::tn bacteria (Extended Data Fig. 7a,b) ), and treatment with the proteasome inhibitor MG132 or the mTORC1 inhibitor rapamycin, which activate autophagy, did not increase the number of LC3-positive or polyubiquitin-positive ompB STOP ::tn bacteria (Extended Data Fig. 7c,d ). Furthermore, almost all LC3-positive ompB STOP ::tn were polyubiquitin-positive ( Fig. 5k and Extended Data Fig. 7e ) and treatment with PYR-41 reduced the percentage of polyubiquitin-positive and LC3-positive ompB STOP ::tn bacteria (Extended Data Fig. 7f ,g). This indicates that ubiquitylation is required for LC3 recruitment. Collectively, these data demonstrate that OmpB blocks the ubiquitylation of R. parkeri to evade autophagic recognition in diverse host cells.
OmpB is required for R. parkeri to evade antimicrobial autophagy in macrophages. To directly test whether OmpB is critical to evade antimicrobial autophagy in macrophages, we employed BMDMs from mice genetically lacking the Atg5 or Becn1 genes in myeloid cells. These mutant cells are defective in both autophagy and LC3-associated phagocytosis 43 . The BMDMs were infected with ompB STOP ::tn and WT R. parkeri, and the bacterial genomic DNA was quantified to assess growth during a 96-h infection. The ompB STOP ::tn bacteria were unable to grow in control Atg5 +/+ (also known as Atg5 flox/flox ) 44 macrophages, whereas WT bacteria grew approximately tenfold ( Fig. 6a ). In contrast, ompB STOP ::tn bacteria in Atg5 −/− (Atg5 flox/flox -LysMcre + ) 45 macrophages grew similarly to the WT during the first 72 h.p.i. (Fig. 6b ). The growth of ompB STOP ::tn was also rescued in Becn1 −/− (Beclin1 flox/flox -LysMcre + ) 46 macrophages ( Fig. 6c ). Although the growth of the ompB STOP ::tn mutant was rescued in Atg5 −/− and Becn1 −/− cells, the mutant was polyubiquitylated (Extended Data Fig. 8a -c), demonstrating that polyubiquitylation does not restrict bacterial growth when the autophagy cascade is prevented. We also tested for bacterial growth in Rubicon −/− macrophages 43 , which are specifically defective in LC3-associated phagocytosis 43 , and growth of the ompB STOP ::tn mutant was not rescued (Extended Data Fig. 8d,e ). These results suggest that the growth of the ompB STOP ::tn mutant is restricted by autophagy but not by LC3associated phagocytosis.
Consistent with being targeted by autophagy, ompB STOP ::tn bacteria co-localized with the lysosomal marker LAMP1, with the number of LAMP1-positive bacteria increasing over time in BMDMs (Fig. 6d ,e) but not in HMECs (Extended Data Fig. 9a,b ). Furthermore, treatment with bafilomycin A, which blocks autophagosome-lysosome fusion and maturation, resulted in the accumulation of mutant bacteria co-localizing with LC3, polyubiquitin or both LC3 and polyubiquitin (Extended Data Fig. 8g -i). The numbers of LAMP1-positive ( Fig. 6f ) and LC3/polyubiquitin-positive (Extended Data Fig. 8f ) ompB STOP ::tn bacteria were reduced in Becn1 −/− macrophages, consistent with the role of beclin 1 in autophagy 17, 18 . Together, these results demonstrate that OmpB is critical for R. parkeri to evade destruction by autophagy in macrophages.
OmpB is important for R. parkeri to colonize mouse organs due to its ability to promote autophagy evasion in immune cells. We next sought to determine whether and how OmpB may contribute to R. parkeri virulence in vivo. We used C57BL/6 mice for these studies because of the availability of mutants in this strain carrying mutations in immunity genes. We injected WT R. parkeri intravenously into the tail-vein of mice, which were then sacrificed daily over a 7 d period and the p.f.u. counts were determined for the spleen, lungs, liver and kidneys. Plaque-forming units were recovered from all these organs, although the mice were asymptomatic and bacteria were cleared between days 4 and 7 (Extended Data Fig. 10a ). Next, we infected the mice with WT or ompB STOP ::tn bacteria; we were unable to recover any ompB STOP ::tn bacteria from any organ within the window of 2 to 72 h.p.i. (Fig. 6g ). Because R. conorii OmpB had been implicated in serum resistance 47 , we also tested whether the ompB STOP ::tn mutant could survive in blood ex vivo over a period of 6 h. The ompB STOP ::tn bacteria remained as infectious as WT over this time (Extended Data Fig. 10b ), suggesting that OmpB does not impact the survival of R. parkeri in blood by itself. These results show that OmpB is a R. parkeri virulence factor, which is critical for establishing an infection in vivo.
We next examined whether OmpB enables autophagy evasion in vivo, similar to its role in cultured macrophages in vitro. To test this, we infected Atg5 −/− mice-which only lack Atg5 in myeloid cells including macrophages-as well as control Atg5 +/+ and C57BL/6 mice with WT and ompB STOP ::tn bacteria. We observed a 5-to 16-fold rescue in the number of ompB STOP ::tn bacteria in the spleens and livers of Atg5 −/− mice compared with Atg5 +/+ and C57BL/6 mice, and the mutant bacteria reached levels that did not differ significantly from the WT (Fig. 6h ). These findings demonstrate that OmpB plays a major role in R. parkeri colonization of mice because of its ability to promote autophagy evasion in immune cells.
Discussion
Bacterial pathogens that grow in the cytosol of host cells often avoid recognition by innate immune pathways, including antimicrobial autophagy. Here, we demonstrate that the R. parkeri surface protein OmpB is critical for protecting against autophagic recognition by blocking the formation of a polyubiquitin coat. We further show that OmpB is critical for the growth of R. parkeri in cultured macrophages through its role in autophagy evasion. Finally, our data suggest that OmpB is critical for R. parkeri to colonize mouse organs due to its ability to promote autophagy evasion in vivo. Together, these data indicate that OmpB acts as a protective shield to inhibit antimicrobial autophagy and as a critical virulence factor in Rickettsia pathogenesis.
Our work also demonstrates that OmpB protects the bacterial surface protein OmpA from ubiquitylation, thereby establishing OmpA as a specific bacterial target of the ubiquitylation machinery. Additional rickettsial surface proteins, such as OmpW, are also likely to be ubiquitylated targets that contribute to ubiquitin coat formation. Interestingly, OmpA is a conserved outer membrane protein in Gram-negative bacteria and was previously identified as a candidate ubiquitylated protein on Salmonella enterica Typhimurium 48 . We thus hypothesize that OmpA may be a common bacterial target for the host ubiquitin machinery.
We further show that OmpB protects R. parkeri from polyubiquitylation by acting locally on the bacterial surface, rather than globally on the host ubiquitylation machinery. However, it remains unclear exactly how OmpB exerts its protective activity, and the mechanisms could be multifaceted. For example, it is possible that OmpB has deubiquitylase activity. Alternatively, OmpB may 
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camouflage the bacterial surface, either directly and/or via its role in the formation of a capsule-like halo. In support of these hypotheses, OmpB makes up more than 10% of the cellular protein mass 35 and is thus abundant enough for a camouflaging role. Moreover, a role for the OmpB-dependent capsule-like halo would be consistent with speculation that the capsular O-antigen shields Francisella tularensis from ubiquitylation 23 . A third possibility is that OmpB recruits host proteins that camouflage the bacterial surface or cleave polyubiquitin chains. A fourth possibility is that OmpB possesses an enzymatic activity that alters properties of the bacterial surface required for recognition by the host ubiquitin machinery. Our data suggest that OmpB is required for R. parkeri to evade autophagy in immune cells during the initial colonization of mice. However, it remains unclear whether OmpB protects R. parkeri from autophagy during long-term infections in vivo. Although we find that OmpB is not required for autophagy avoidance in endothelial cell lines in vitro, it was previously observed that rickettsiae can be found in the autolysosomes of cytokine-treated mouse endothelial cells 49 , which suggests that bacteria could be targeted by autophagy during long-term infection following release of inflammatory cytokines 50 .
OmpB seems to act differently from other pathogen proteins that protect against polyubiquitylation. For example, the L. monocytogenes surface protein ActA blocks polyubiquitylation by mobilizing the host actin machinery to the bacterial surface, which is required to protect the bacterium from autophagic recognition 11, 25, 51 . In contrast, OmpB has no effect on host actin mobilization by R. parkeri. In addition, a subpopulation of WT L. monocytogenes is polyubiquitylated during intracellular growth 11, 22, 52 , whereas nearly all R. parkeri are polyubiquitin negative, suggesting that OmpB is a more robust shield, perhaps because its mechanism may not involve the recruitment of host components such as the actin machinery. Thus, although cytosolic pathogens have evolved a common strategy of using abundant surface proteins to block host polyubiquitylation, the mechanism by which each protein acts as a shield is distinct. Understanding the commonalities and differences in how pathogen proteins protect against polyubiquitylation and autophagy will enhance our understanding of the pathogenic strategies for the avoidance of innate immunity and might be co-opted as a therapeutic strategy for treating infectious disease.
Methods
Cell lines. HMEC-1, A549 and Vero cells were purchased from the UC Berkeley Cell Culture Facility and authenticated by short-tandem-repeat analysis. All cells were grown at 37 °C and 5% CO 2. The HMECs were grown in MCDB 131 media containing 10 mM l-glutamine (Sigma, M8537), supplemented with 10% heat-inactivated fetal bovine serum (Hi-FBS; Hyclone), 10 ng ml −1 epidermal growth factor (Fisher Scientific, CB40001; Corning, cat. no. 354001), 1 μg ml −1 hydrocortisone (Spectrum Chemical, CO137) and 1.18 mg ml −1 sodium bicarbonate. Fresh HMEC media was prepared every 1-2 months, aliquoted and stored at 4 °C before use in experiments or to passage cells to minimize degradation of epidermal growth factor. The A549 cells were grown in DMEM medium (Gibco, 11965-092) with high glucose (4.5 g l −1 ) and 10% Hi-FBS (Atlas Biologicals). The Vero cells were grown in DMEM (Gibco, 11965-092) with high glucose (4.5 g l −1 ) and 2% Hi-FBS (Benchmark). All cell lines were confirmed to be mycoplasma negative by 4,6-diamidino-2-phenylindole (DAPI) staining and fluorescence microscopy screening at the UC Berkeley Cell Culture Facility.
Primary macrophage cells.
Wild-type BMDMs were generated from the femurs of female C57BL/6 mice (Charles River Laboratories) according to standard protocols 54 . Briefly, the flesh was removed and the bones were washed in 70% ethanol and then with BMDM media (DMEM high glucose; Gibco, 11965-092) containing 20% Hi-FBS (Hyclone), 10% supernatant from NIH 3T3 fibroblasts that produced macrophage colony-stimulating factor, 1% sodium pyruvate (Gibco, 11360-070), 100 U ml −1 penicillin, 100 μg ml −1 streptomycin (Gibco) and 0.1% β-mercaptoethanol (Gibco, 21985-023). Next, the bones were crushed with a mortar and pestle and cells were filtered through a 70-μm nylon Corning Falcon cell strainer (Thermo Fisher Scientific, 08-771-2) to remove particulates. The cells were centrifuged at 290g for 8 min and 4 °C, the cell pellet was resuspended in BMDM medium and incubated at 37 °C for 7 d before harvesting in medium lacking antibiotics.
The percentage of CD11b + F4/80 + BMDMs was determined by blocking cells with anti-mouse CD16/32 (Biolegend, cat. no. 101320) and then staining with PE-Cyanine7 anti-mouse F4/80 antigen antibody (1:200 dilution; Tonbo Bioscience, cat. no. 604801), APS anti-mouse CD11b (1:250 dilution; Tonbo Bioscience, cat. no. 200112) and DAPI (1:1,000 dilution). The samples were subjected to flow cytometry using a BD LSRFortessa 2010 Cell Analyzer (BD Biosciences) and data were analysed using FlowJo software (FlowJo, LLC). Single viable DAPInegative cells were gated and the percentage of CD11b + F4/80 + macrophages was determined to be 99.4% ( Supplementary Fig. 1 ).
Mutant BMDMs were isolated from the femurs of mutant mice. The femurs from female Atg5 +/+ (ref. 44 ) and matched Atg5 −/− (ref. 45 ) C57BL/6 mice were from the laboratory of J.S.C. (UC Berkeley). Femurs from female Becn1 −/− (ref. 46 ), Rubicon +/+ and Rubicon −/− (CRISPR/Cas9-mediated mutations) 43 mice were obtained from D. Green (St. Jude Children's Research Hospital). The BMDMs were prepared as described above. The genotypes of the BMDMs were confirmed by PCR and Sanger sequencing at the UC Berkeley DNA Sequencing Facility with the following primers: 5ʹ-GCAGAAGTTGAAGCACCTAGTCACACCAC-3ʹ and 5ʹ-C TGCATAATGGTTTAACTCTTGSTAGACTAGTCA-3ʹ for Atg5 +/+ and Atg5 −/− , 5ʹ-CTGCAGCGTATCTCAGGTG-3ʹ and 5ʹ-CCAAGGTTTCCATGCTAATGC-3ʹ for Becn1 −/− , and 5ʹ-GCCTTCCTGCTGAGTGACG-3ʹ and 5ʹ-GTCATGGGCTCCCGTGGC-3ʹ for Rubicon +/+ and Rubicon −/− BMDMs.
R. parkeri propagation and enumeration.
For the propagation of R. parkeri, five T175 flasks of Vero cells growing in DMEM medium plus 2% Hi-FBS were infected at a multiplicity of infection (m.o.i.) of about 0.01 and incubated until 50-75% of the cells were infected (after 5-7 d). The cells were scraped into the growth media, collected in cold centrifuge bottles and centrifuged at 12,000g for 20 min at 4 °C. The cell pellet was resuspended in cold K-36 buffer (0.05 M KH 2 PO 4 , 0.05 M K 2 HPO 4 , pH 7, 100 mM KCl and 15 mM NaCl) and transferred to a cold dounce homogenizer (tight fit). The cells were dounce-homogenized for 60 strokes to release the bacteria and the homogenate was centrifuged at 200g for 5 min at 4 °C to remove the cell debris. To yield '30%-purified' bacteria, the supernatant was overlaid onto cold 30% MD-76R (Mallinckrodt Inc., 1317-07), diluted in K-36 buffer and centrifuged at 58,300g for 20 min at 4 °C in an SW-28 swinging-bucket rotor. The pellet was resuspended in cold brain-heart-infusion (BHI) broth (BD Difco, cat. no. 237500; 0.5 ml per infected T175 flask) and subsequently aliquoted and frozen at −80 °C. For further purification, the bacteria were overlaid on a 40/44/54% MD-76R step gradient and centrifuged at 58,300g for 30 min at 4 °C using a SW-28 swinging bucket rotor to yield 'gradient-purified' bacteria. The bacteria were collected from the 44-54% interface and subsequently pelleted by centrifugation at 12,000g for 15 min at 4 °C. The pellet was resuspended in BHI broth and subsequently aliquoted and frozen at −80 °C. Fresh vials of bacteria were used in all experiments to avoid experimental variations due to the loss of bacterial infectivity following freezing-thawing. Stocks of WT and ompB STOP ::tn mutant bacteria were prepared approximately every six months and side-by-side experimental comparisons were made between stocks prepared at similar times.
To enumerate the infectious bacteria, the purified bacterial strains were serially diluted in DMEM medium with 2% Hi-FBS and used to infect Vero cells grown in six-well plates by centrifugation at 300g for 5 min at room temperature. The infections were allowed to proceed overnight (about 16 h) at 33 °C and then the cells were overlaid in DMEM with 10% Hi-FBS plus 0.5% (w/v) UltraPure agarose (Invitrogen, 16-500). At 5-7 d post infection, when plaques could be visualized, the cells were further overlaid with PBS plus 0.5% UltraPure agarose containing 0.0125% (v/v) neutral red (Sigma, N6264) and incubated at 33 °C. The plaques were enumerated the next day to determine the p.f.u. counts per millilitre. For the bacterial growth curves, 30%-purified bacteria were diluted in the appropriate media to an m.o.i. of 0.005-0.01 for the infection of HMECs and 0.25-0.5 for the infection of BMDMs (a higher m.o.i. was used for BMDMs to compensate for the reduced bacterial growth rate in these cells). R. parkeri infections were carried out in 24-well plates. The bacteria were centrifuged onto cells at 300g for 5 min at room temperature and then incubated at 33 °C for 1 h, at which point the culture media was exchanged. Cells were scraped off into the media at various times post infection (including the 1 h time point)-to include both intracellular and extracellular bacteria-centrifuged at 20,000g for 5 min at room temperature and the pellets were stored at −20 °C until the DNA was purified using a DNeasy blood and tissue kit (Qiagen) according to the manufacturer's instructions for Gram-negative bacteria. The R. parkeri genome equivalents were quantified by quantitative PCR (qPCR) using the primers 5ʹ-CGCCATTCTACGTTACTACC-3ʹ and 5ʹ-GCATTACTTGGAGTTCT-3ʹ to the hrtA gene, relative to a standard curve of hrtA gene DNA 55 . Growth was normalized to the values at 1 h.p.i. for each strain.
R. parkeri strain generation. The R. parkeri ompA::tn, hrtA::tn, sca2::tn and ompB::tn mutant strains were previously isolated in a screen for small plaque mutants 33, 38, 56 . The ompA::tn mutant lacked full-length OmpA, as determined by western blotting using the mouse anti-OmpA 13-3 antibody (provided by T. Hackstadt 29, 57 ; Extended Data Fig. 1f ). The MC1_RS05535::tn, MC1_RS05545::tn and rickCE::tn strains were isolated in an independent screen, in which mutants were isolated without regard for plaque size. The genomic locations of the transposon insertion sites for all mutants were determined by semi-random nested Articles NAturE MIcrOBIOlOgy PCR and Sanger sequencing at the UC Berkeley DNA Sequencing Facility, as previously described 58 . The expanded strains were verified by either semi-random nested PCR or PCR reactions that amplified the transposon insertion site using primers to the flanking regions.
The ompB STOP ::tn, MC1_RS02370 STOP , ompB::tn and ompB PROM ::tn strains were isolated in a screen for mutations that suppress the slow-growth phenotype of ompB::tn. To obtain strains carrying the suppressor mutations, two independent selections were carried out, in which the ompB::tn strain was subjected to ten serial passages in Vero cells growing in T75 flasks in DMEM medium with 2% Hi-FBS, with the length of each passage varying from 5 to 7 d, depending on the rate of bacterial growth. For each passage, cells were lysed by the addition of 1 ml cold sterile water per T75 flask for 1-2 min at room temperature. Subsequently, 1 ml of cold 2×BHI was added to the lysed cells, approximately 10% of the suspension was added to DMEM plus 2% Hi-FBS and this was used to infect a fresh T75 flask of Vero cells. The remaining bacteria were frozen at −80 °C. To map suppressor mutations in the mixed population, clonal strains were isolated and larger plaques were selected and expanded in Vero cells, as described above. The genome sequences of three strains from each suppressor screen, which had been passaged four or five times, were determined (National Center for Biotechnology Information (NCBI) Trace and Short-Read Archive; Sequence Read Archive accession no. SRP154218), as were the sequences of the parental ompB::tn (individual accession no. SRX4401163) and WT R. parkeri strains (SRX4401164), as described below. The strains were isogenic with the exception of the suppressor mutations in the following locations: the MC1_RS02370 gene, encoding a putative glycosyltransferase (the same mutations in four of six clonal strains, accession no. SRX4401165); the promoter region of ompB (ompB PROM ::tn; one clonal strain, accession no. SRX4401166) and upstream of the transposon in the coding sequence of ompB, leading to a premature stop codon (ompB STOP ::tn; one clonal strain, accession no. SRX4401167; See also Extended Data Fig. 1a-c) .
R. parkeri genome sequencing. Rickettsia genomic DNA was isolated from frozen bacterial stocks (approximately 10 8 p.f.u.; stored in BHI broth), which were centrifuged at 16,000g for 5 min at room temperature and resuspended in Dulbecco's PBS with calcium and magnesium (Invitrogen, cat. no. 14040) containing DNase reaction buffer and 100 U recombinant RNase-free DNase 1 (Roche, cat. no. 04716728001) to reduce the host genomic DNA in the final sample, as described previously 59 . The intact bacteria were incubated at 37 °C for 30 min and washed twice with Dulbecco's PBS. Subsequently, the rickettsial genomic DNA was purified using the DNeasy blood and tissue kit (Qiagen) according to the manufacturer's instructions for Gram-negative bacteria. To confirm that the Rickettsia genomic DNA was largely intact, we verified that the DNA fragments were mostly >20,000 bp by agarose gel electrophoresis. The genome sequences of the R. parkeri strains (three strains from each suppressor screen as well as parental ompB::tn and WT strains) were determined at the UC Berkeley Functional Genomics Laboratory using single-end 50-bp read lengths on the Illumina Hiseq2000 sequencing platform. Genome assembly as well as single nucleotide variant and indel identification were performed using the CLC Genomics Workbench (Qiagen) and Integrated Genomics Viewer 60 . The genome of the R. parkeri strain Portsmouth (GenBank accession no. NC_017044.1) was used as the reference sequence. The mutations identified by genome sequencing were confirmed by PCR followed by Sanger sequencing at the UC Berkeley DNA Sequencing Facility.
OmpB antibody production and western blotting. The sequence encoding amino acids 36-218 of OmpB (ompB aa36-218 ), a protein that lacks the signal peptide and stops at the same position as the fragment encoded in the ompB STOP ::tn suppressor strain (Extended Data Fig. 1c ), was amplified by PCR from R. parkeri genomic DNA. Next, ompB aa36-218 was cloned into the pSMT3 plasmid, which encodes N-terminal 6×His and SUMO tags 61 . From the resulting plasmid, 6×His-SUMO-OmpB aa36-218 was expressed in Escherichia coli strain BL21 codon plus RIL-Cam r (DE3; QB3 Macrolab, UC Berkeley) by induction with 0.1 mM isopropyl-β-d-thio-galactoside for 16 h at 16 °C. The bacterial pellets were resuspended in lysis buffer (50 mM NaH 2 PO 4 , pH 8.0, 300 mM NaCl and 10 mM imidazole) and stored at −80 °C. For protein purification, the bacteria were thawed, lysozyme was added to 1 mg ml −1 (Sigma, L4919) and lysis was carried out by sonication. The lysate containing 6×His-SUMO-OmpB was incubated with Ni-NTA resin (Qiagen, cat. no. 1018244) and the bound proteins were eluted with a step gradient of 100, 250 and 500 mM imidazole (in lysis buffer, pH adjusted to 8.0). The fractions were analysed by SDS-PAGE and those with the highest concentrations of 6×His-SUMO-OmpB 36-218 were pooled before desalting, using PD-10 desalting columns (GE Healthcare, cat. no. 17085101) and equilibrated with lysis buffer lacking imidazole.
To generate rabbit antibodies against OmpB, 0.8 mg purified 6×His-SUMO-OmpB protein was sent to the Pocono Rabbit Farm and Laboratory, and immunization was carried out according to their 91 d protocol. To affinity purify the anti-OmpB antibodies, ompB aa36-218 was subcloned into the pET1M plasmid, which encodes N-terminal 6×His and maltose-binding protein (MBP) tags. From the resulting plasmid, 6×His-MBP-OmpB aa36-218 was expressed and induced as above for His-SUMO-OmpB aa36-218 . The bacterial pellets were resuspended in column buffer (50 mM NaH 2 PO 4 , pH 8.0, 300 mM NaCl, 1 mM EDTA and 1 mM dithiothreitol) and the fusion protein was purified by affinity chromatography on amylose resin (New England Biolabs, E8021L). The bound proteins were eluted in column buffer lacking EDTA and containing 10 mM maltose. The purified protein (500 μg) was then coupled to NHS-activated Sepharose 4 fast flow resin (GE Healthcare, cat. no. 17090601) in ligand-coupling buffer (200 mM NaHCO 3 , pH 8.3 and 500 mM NaCl) overnight at 4 °C. The resin was incubated with 10 ml anti-OmpB serum diluted in binding buffer (20 mM Tris, pH 7.5), which was loaded on the resin and incubated for 3 h at 4 °C, eluted with 100 mM glycine pH 2.5 and neutralized 62 .
For western blotting of endogenous OmpB, OmpA, RickA and polyubiquitin, 30%-purified or gradient-purified bacteria were boiled for 10 min in 1×SDS loading buffer (150 mM Tris, pH 6.8, 6% SDS, 0.3% bromophenol blue, 30% glycerol and 15% β-mercaptoethanol). Next, 1-5 × 10 6 p.f.u. were resolved on an 8-12% SDS-PAGE gel and transferred to an Immobilon-FL PVDF membrane (Millipore, IPEL00010). The membranes were probed for 30-60 min at room temperature with antibodies as follows: affinity-purified rabbit anti-OmpB antibody (this study) diluted 1:10,000 in TBS-T (20 mM Tris, 150 mM NaCl, pH 8.0 and 0.05% Tween 20 (Sigma, P9416)) plus 5% dry milk (Apex, 20-241); mouse monoclonal anti-OmpA 13-3 antibody diluted 1:20,000 in TBS-T plus 5% dry milk; affinity-purified rabbit anti-RickA antibody 63 diluted 1:1,000 in TBS-T plus 5% dry milk or mouse monoclonal FK1 anti-polyubiquitin antibody (Enzo Life Sciences, BML-PW8805-0500) diluted 1:2,500 in TBS-T plus 2% BSA. The secondary antibodies used were mouse anti-rabbit horseradish peroxidase (Santa Cruz Biotechnology, sc-2357) or goat anti-mouse horseradish peroxidase (Santa Cruz Biotechnology, sc-2005), both diluted 1:2,500 in TBS-T plus 5% dry milk. The secondary antibodies were detected with ECL western blotting detection reagents (GE Healthcare, RPN2106) for 1 min at room temperature and developed using Biomax Light Film (Carestream, 178-8207).
Immunofluorescence microscopy. R. parkeri infections were carried out in 24-well plates with sterile circular 12-mm coverslips (Thermo Fisher Scientific, 12-545-80). To infect HMECs, 2 × 10 5 cells were seeded into each well and the cells were then infected after 2 d. To infect BMDMs, 4-5 × 10 5 cells were seeded into each well and infection was conducted after 16-20 h. To initiate infection, 30%-purified bacteria were diluted in cell culture media at room temperature to an m.o.i. of 0.005-0.01 for HMECs and 0.25-0.5 for BMDMs. The higher m.o.i. for the macrophage infection was employed due to the reduced bacterial growth rate in these cells. The bacteria were centrifuged onto cells at 300g for 5 min at room temperature and subsequently incubated at 33 °C for 1 h. The medium was exchanged at 1 h.p.i. For the experiments with PYR-41 (Millipore, cat. no. 662105), HMECs were infected and treated with the drug in one of two ways: (1) infected at an m.o.i. of 2-4, supplemented with the DMSO-dissolved drug (50 μM final concentration; PYR-41 was diluted in pre-warmed HMEC media, followed by swirling the tube and incubation at 37 °C for 5 min) or the corresponding volume of DMSO at 1 h.p.i. and then incubated at 37 °C until 5 h.p.i. or (2) infected at an m.o.i. of 0.005-0.01, supplemented with the DMSO-dissolved drug (50 μM final concentration after dilution in cell culture media) or the corresponding volume of DMSO at 66 h.p.i. and incubated at 37 °C until 72 h.p.i. For the experiments with bafilomycin A (Sigma, B1793), BMDMs infected at an m.o.i. of 2-4 were supplemented with the DMSO-dissolved drug (300 nM final concentration) or the corresponding volume of DMSO at 1 h.p.i., incubated at 33 °C and fixed at 1, 2.5 and 4 h.p.i. (3 h after the drug was supplemented). For the experiments with rapamycin (Tocris Bioscience, cat. no. 1292) and MG132 (Sigma, M8699), HMECs infected with an m.o.i. of 2-4 were supplemented with the DMSO-dissolved drugs (final concentration of 500 nM rapamycin and 20 μM MG132) or DMSO-volume corresponding to of MG132-at 1 h.p.i., incubated at 33 °C and fixed at 4 h.p.i. (3 h after the drug was supplemented), as described above.
For immunofluorescence microscopy, infected cells were fixed for 10 min at room temperature in pre-warmed (37 °C) 4% paraformaldehyde (Ted Pella Inc., cat. no. 18505) diluted in PBS, pH 7.4, and then washed three times with PBS. The cells were permeabilized with 0.5% Triton X-100 for 5 min before staining with the following primary antibodies: guinea pig polyclonal anti-p62 antibody (1:500 dilution; Fitzgerald, 20R-PP001), mouse polyclonal anti-NDP52 antibody (1:100 dilution; Novus Biologicals, H00010241-B01P), rabbit monoclonal anti-M1 (linear) polyubiquitin linkage-specific antibody (1:250 dilution; Millipore, MABS199), rabbit monoclonal anti-K63 polyubiquitin linkage-specific antibody (1:250 dilution; Millipore, 05-1308), human anti-K48 polyubiquitin linkage-specific antibody (clone 5B6 64 ; final concentration 0.2 μg ml −1 ) and anti-polyubiquitin FK1 antibody (1:250 dilution). For staining with the mouse monoclonal anti-LC3 (clone 2G6, 1:500 dilution; NanoTools, 0260-100), rabbit polyclonal anti-LC3 (1:250 dilution; Novus Biologicals, NB100-2220SS), rat anti-mouse-LAMP1 (1:250 dilution; Biolegend, cat. no.121609), mouse anti-human-LAMP1 (1:25 dilution; BD Bioscience, cat. no. 555801) and rabbit polyclonal anti-OmpB (this study; 1:1,000 dilution) antibodies, the cells were post-fixed in 100% methanol for 5 min at room temperature. The cells were washed three times with PBS and incubated with the primary antibody, diluted as indicated in PBS with 2% BSA for 30 min at room temperature. To detect the primary antibodies, secondary goat antirabbit Alexa 568 (Invitrogen, A11036), goat anti-mouse Alexa 568 (Invitrogen, A11004), goat anti-human Alexa 488 (Invitrogen, A11013), goat anti-rat Alexa Articles NAturE MIcrOBIOlOgy 568 (Invitrogen, A11077) or goat anti-guinea pig Alexa 568 (Invitrogen, A11075) antibodies were incubated at room temperature for 30 min (all 1:500 in PBS with 2% BSA). Next, rabbit anti-Rickettsia I7205 (gift from T. Hackstadt) 57 or a mouse monoclonal anti-Rickettsia 14-13 (gift from T. Hackstadt) 57 antibody (1:500 dilution for both) was used to detect R. parkeri. The secondary antibodies used were: Alexa 488 anti-rabbit antibody (1:500 dilution; Invitrogen, A11008), Alexa 405 anti-rabbit antibody (Invitrogen, A31556), Alexa 488 anti-mouse antibody (1:500 dilution; Invitrogen, A11001) or Alexa 405 anti-mouse antibody (1:150 dilution; Invitrogen, A31553). Actin filaments were visualized in samples fixed with 4% paraformaldehyde and permeabilized with 0.5% Triton X-100 using Alexa 488 phalloidin (1:500 dilution; Life Technologies, P3457) or Alexa 568 phalloidin (1:500 dilution; Life Technologies, A12380). Images were captured as z-stacks (0.1μm step size) on a Nikon Ti Eclipse microscope with a Yokogawa CSU-XI spinning disc confocal with ×60 and ×100 (1.4 numerical aperture) Plan Apo objectives and a Clara Interline CCD Camera (Andor Technology) using MetaMorph software (Molecular Devices). The rendered z-stacks were used for quantifications. The images were processed using ImageJ 65 and assembled in Adobe Photoshop. Identical image adjustments for each colour were applied to all bacterial strains in each experiment. To prepare representative images, we used a single optical section, in which most or all bacteria were in that focal plane. The only exceptions were for representative images of LAMP1 or LC3/polyubiquitin staining, for which we used z-stack average maximum intensity projections.
Only bacteria that co-localized with rim-like patterns of the respective marker were scored as positive for staining for the quantification of polyubiquitin, polyubiquitin linkages, p62 and NDP52 staining. For the quantification of LC3 staining, bacteria that co-localized with either LC3 clouds or puncta were considered positive for staining. ompB STOP ::tn bacteria were occasionally not stained adequately with the anti-Rickettsia antibodies in macrophage infections that extended beyond 60 min; we therefore included Hoechst (Sigma, B2261) staining in all experiments to detect the bacterial genomic DNA.
To determine the frequency of bacterial internalization, infections were carried out as described earlier, except that bacteria were diluted in media at 4 °C to a m.o.i. of 5 in 500 μl cell culture media, which was added to each well, and centrifuged at 300g for 5 min at 4 °C. For the 0-min time point, coverslips were transferred to 4% paraformaldehyde immediately after the centrifugation step, fixed for 10 min and washed three times with 1×PBS, pH 7.4. To initiate invasion/internalization, 500 μl media at 37 °C was added to each well and the plate was transferred to 33 °C. The cells were fixed at 5, 10, 15, 20, 30, 60 and 90 m.p.i. as described above. Rabbit anti-Rickettsia I7205 antibody (or rabbit anti-Rickettsia R2868 antibody (a gift from T. Hackstadt) for the ompA::tn mutant) and a secondary Alexa 405-conjugated antirabbit antibody (Invitrogen, A31556) were used for immunofluorescence staining of extracellular bacteria. To subsequently stain all bacteria (intracellular and extracellular), the cells were permeabilized with 0.5% Triton X-100 (Sigma, T9284) for 5 min and the anti-Rickettsia I7205 antibody (or rabbit anti-Rickettsia R2868 antibody to detect the ompA::tn mutant) and a secondary Alexa 488-conjugated goat anti-rabbit antibody (Invitrogen, A11008) were used. Coverslips were mounted with Prolong Gold anti-fade (Invitrogen, P36930) and stored at 4 °C before imaging. Imaging was carried out as described earlier and the percentage of internalized/intracellular bacteria was calculated by first dividing the number of extracellular bacteria by the total number of bacteria, multiplying by 100 and then subtracting this number from 100%.
TEM.
For the TEM experiments, infection of HMECs and BMDMs was performed as described above for the internalization assays. The medium was removed at 1 h.p.i. and fixative (1.5% paraformaldehyde, 2.0% glutaraldehyde and 0.03% CaCl 2 in 0.05 M cacodylate buffer, pH 7.2) was added to each well for 45 min at room temperature, as previously described 66 . The samples were embedded in 2% lowmelting agarose and incubated overnight at 4 °C in 2.0% glutaraldehyde and 0.1 M cacodylate buffer, pH 7.2. The samples were post-fixed the following day in 1% osmium tetraoxide and 1.6% potassium ferricyanide, dehydrated in a graded series of ethanol concentrations and embedded in EPON 812 resin prepared as follows: 11.75 g Eponate 12 (Ted Pella Inc., cat. no. 18005), 6.25 g dodecenyl succinic anhydride (Ted Pella Inc., cat. no. 18022) and 7 g nadic methyl anhydride (Ted Pella Inc., cat. no. 18032) were mixed before the addition of 0.375 ml of the embedding accelerator benzyldimethylamine (Ted Pella Inc., cat. no. 18241). Next, the samples were stained with 2% uranyl acetate and lead citrate. Images were obtained on a FEI Tecnai 12 transmission electron microscope. The radius of the halo (r halo or halo thickness) was calculated by measuring the area of the bacterium plus halo (A total ) and bacterium minus halo (A bacterium ), assuming circularity and calculating the radius of each as r ¼ ffiffiffiffiffiffiffiffi ffi A=π p I and then calculating r halo = r total − r bacterium 67 .
TUBE assay and sample preparation for mass spectrometry. To enrich for polyubiquitylated proteins, 4 × 10 8 p.f.u. 30%-purified or 4 × 10 7 p.f.u. gradientpurified WT and ompB STOP ::tn bacteria were centrifuged at 20,000g for 3 min at room temperature. Next, to release the surface protein fraction, the bacterial pellets were resuspended in lysis buffer (50 mM Tris-HCI, pH 7.5, 150 mM NaCl, 1 mM EDTA and 10% glycerol), supplemented with 0.0031% (v/v) lysonase (Millipore, cat. no. 71230), the deubiquitylase inhibitor PR619 at a final concentration of 20 μM (Life Sensor, SI9619) and 0.8% (w/v) octyl β-d-glucopyranoside (Sigma, O8001), and incubated on ice for 10 min. The lysate was subsequently cleared by centrifugation at 14,000g for 5 min at 4 °C and incubated with equilibrated agarose TUBE-1 (Life Sensor, UM401) for 4 h at 4 °C. After the binding of polyubiquitylated proteins to TUBE-1, the agarose beads were washed three times with TBS (no Tween) and centrifuged at 5,000g for 5 min. The enriched proteins were digested overnight at 37 °C on agarose beads in RapiGest SF solution (Waters, 186001861) supplemented with about 0.5 μg trypsin (Promega, V511A) to prepare the samples for mass-spectrometry analysis. The reaction was stopped using 1% trifluoroacetic acid (Sigma, T6508). Octyl β-d-glucopyranoside was extracted using water-saturated ethyl acetate, as previously described 68 . Before submitting for mass-spectrometry analysis, the samples were desalted using C18 OMIX tips (Agilent Technologies, A57003100) according to the manufacturer's instructions.
Liquid chromatography-mass spectrometry. The samples of proteolytically digested proteins were analysed using a Synapt G2-Si mass spectrometer, which was equipped with a nanoelectrospray ionization source (Waters). The mass spectrometer was connected in line with an Acquity M-class ultra-performance liquid chromatography system equipped with trapping (Symmetry C18; inner diameter, 180 μm; length, 20 mm and particle size, 5 μm) and analytical (HSS T3; inner diameter, 75 μm; length, 250 mm; particle size, 1.8 μm) columns (Waters). Data-independent, ion mobility-enabled, high-definition mass spectra and tandem mass spectra were acquired in the positive ion mode [69] [70] [71] . Data acquisition was controlled using MassLynx software (version 4.1), and tryptic peptide identification and relative quantification using a label-free approach 72 To validate OmpA as a polyubiquitylated substrate on ompB STOP ::tn bacteria, confluent Vero, A549 and HMEC cells grown in six-well plates were transfected and infected as described above, with the exception that HMECs and A549s were transfected for only 60 min. The cells were washed once with 1×PBS (this step was excluded for HMECs), pH 7.4, at 26 h.p.i. and subsequently lysed in urea lysis buffer (8 M urea, 50 mM Tris-HCI, pH 8.0, 300 mM NaCI, 50 mM Na 2 HPO 4 and 0.5% Igepal CA-630 (Sigma, I8896)) for 20 min at room temperature (the volume of lysis buffer was reduced 2× for HMECs). The samples were then sonicated and the lysate was cleared by centrifugation at 15,000g for 15 min at room temperature. An aliquot was saved for the input sample before incubation with Ni-NTA resin. The 6×His-ubiquitin conjugates were purified by incubation and rotation with the Ni-NTA resin for 4 h at room temperature. The beads were washed three times with urea lysis buffer and once with urea lysis buffer lacking Igepal CA-630. The ubiquitin conjugates were eluted at 65 °C for 15 min in 2×Laemmli buffer containing 200 mM imidazole and 5% β-mercaptoethanol (Sigma, M6250), vortexed for 1 min and centrifuged at 5,000g for 3 min. Eluted and input proteins were detected by SDS-PAGE followed by western blotting, as described above.
Bacterial viability assay.
To assess the integrity of the bacterial membrane, confluent HMEC cells were infected with 30%-purified WT and ompB STOP ::tn bacteria, as described earlier for the invasion/internalization experiments. After centrifugation at 300g for 5 min at 4 °C (considered the 0 min time point), the cells were washed once in KHM buffer (110 mM CH 3 CO 2 K, 2 mM Mg(CH3COO) 2 and 20 mM HEPES, pH 7.2), incubated in KHM buffer with or without 50 μg ml −1 digitonin (positive control) for 1 min and subsequently incubated in 2.6 μM propidium iodide (Molecular Probes, P-3560) diluted in KHM buffer for 10 min at room temperature, as previously described 23, 74 . The cells were then washed once in KHM buffer, fixed in 4% paraformaldehyde and stained for bacteria using the anti-Rickettsia 14-13 antibody and a secondary goat anti-mouse Alexa 488 antibody (Invitrogen, A11004), as described above.
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LDH-release host cell viability assay. Supernatants from infected or uninfected BMDMs were collected at 96 h.p.i. and then mixed with 2×LDH buffer (100 μg ml −1 tetrazolium salt (in PBS; Sigma, I18377), 150 μg ml −1 β-nicotineaminde adenine dinucleotide hydrate (Sigma, N3014), 0.675 U ml −1 diaphorase (Sigma, D5540), 0.06% sucrose, 12 mg ml −1 lithium lactate (resuspended in 10 mM Tris-HCl pH 8.5 to 36 mg ml −1 ; Sigma, L2250) and 0.25% BSA in PBS). The supernatant from uninfected cells lysed with 1% Triton X-100 was used to calculate 100% lysis. The reactions were incubated at room temperature for 20 min before reading at 490 nm absorbance using an Infinite F200 Pro plate reader (Tecan). The values were divided by the difference between cells lysed with Triton X-100 and the experimental supernatants, and multiplied by 100 to calculate the percentage of lysis.
Animal experiments. Female C57BL/6 mice were purchased from Charles River Laboratories and 8-to 10-week-old littermates were used for each experiment. The groups that received different bacterial strains were randomly assigned. The C57BL/6 Atg5 +/+ mice were from N. Mizushima (Tokyo Medical and Dental University) 44 and Atg5 −/− C57BL/6 mice were a gift from H. Virgin (University of Washington) 75 . The mice were genotyped as previously described 45 using primers exon3-1, short2 and check2 for the detection of the Atg5 gene and primers cre1 and cre2 for the detection of the cre gene. Randomly assigned 8-to 10-week-old male and female Atg5 +/+ and Atg5 −/− C57BL/6 mice were used in the experiments comparing these genotypes. These experiments were not performed blinded. The sample size for mice experiments was chosen based on the results between two groups after the first experiment, in which 2-3 mice per group were used. The mice were housed in specific-pathogen-free conditions and euthanized according to standard protocols approved by UC Berkeley Animal Care and Use Committee.
The mice were infected with 10 7 p.f.u. WT or ompB STOP ::tn bacteria diluted in 200 μl 1×PBS, pH 7.4 (Gibco, cat. no.1001023), via injection into the lateral tail vein. The bacteria were enumerated using a plaque assay, as described above, immediately after injection to confirm the infectivity and titre of the bacterial strains. The mice were killed at 2, 24, 48 and 72 h.p.i., doused with ethanol, laid on the right side, and the spleen, liver, lungs and kidneys were removed and transferred into cold sterile PBS. The organs were disrupted in a homogenizer (Polytron) for about 10 s and centrifuged at 200g for 5 min. The supernatants were collected to assess the number of p.f.u. per organ using a plaque assay, as described earlier (Fig. 6g ). Due to the moderate toxicity of the organ supernatants on Vero cells (particularly from the liver), we optimized the protocol as follows. Instead of centrifuging the homogenized organs at 200g for 5 min, we employed 300g for 5 min. Subsequently, instead of centrifugation of the supernatants at 300g for 5 min, which we normally use for R. parkeri infections, the supernatants were centrifuged at 230g for 5 min. These minor changes reduced the toxic effects on Vero cells, leading to detectable ompB STOP ::tn and increased WT p.f.u. numbers (Fig. 6h) .
To determine the viability of bacteria in mouse blood, we collected blood from the diaphragm cavity of female mice on dissection. Next, 2 × 10 5 p.f.u. of the WT or ompB STOP ::tn strain were added to 40 μl fresh blood and incubated at 37 °C. At 0, 20, 60, 120, 180 and 360 min, the samples were resuspended and 5 μl was taken for p.f.u. determination using the plaque assay, as described above. The p.f.u. counts were normalized to 0 min for each strain.
Statistical analysis. The statistical parameters and significance are reported in the figure legends. Data were considered to be statistically significant when P < 0.05, as determined by an unpaired Student's t-test, a Mann-Whitney rank-sum test or a one-way ANOVA with Tukey's post-hoc test. Statistical analysis was performed using PRISM 6 software (GraphPad Software).
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The datasets generated and/or analysed during the current study are available from the corresponding authors on request. The genome sequences of bacterial strains are available at the Sequence Read Archive as accession no. SRP154218 (WT, SRX4401164; ompB::tn, SRX4401163; ompB STOP ::tn, SRX4401167; ompB PROM ::tn, SRX4401166 and MC1_RS02370 STOP , ompB::tn, SRX4401165). 
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research Laboratory animals C57BL/6, C57BL/6 ATG5flox/flox-LysMcre (Atg5-/-) and C57BL/6 Atg5flox/flox (Atg5+/+) mice. Mice were housed and euthanized according to standard protocols approved by UC Berkeley Animal Care and Use Committee.
Wild animals
No wild animals were used in this study.
Field-collected samples
No field-collected animals were used in this study.
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Methodology
Sample preparation
BMDMs generated from the C57BL/6 mice were plated on non-TC plates in complete macrophage media and incubated
